Cargando…
Glycolytic inhibition: A novel approach toward controlling neuronal excitability and seizures
Conventional antiseizure medications reduce neuronal excitability through effects on ion channels or synaptic function. In recent years, it has become clear that metabolic factors also play a crucial role in the modulation of neuronal excitability. Indeed, metabolic regulation of neuronal excitabili...
Autores principales: | Shao, Li‐Rong, Rho, Jong M., Stafstrom, Carl E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293058/ https://www.ncbi.nlm.nih.gov/pubmed/30564778 http://dx.doi.org/10.1002/epi4.12251 |
Ejemplares similares
-
2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control
por: Rho, Jong M., et al.
Publicado: (2019) -
Brief history of anti‐seizure drug development
por: Rho, Jong M., et al.
Publicado: (2018) -
Pediatric Epilepsy Mechanisms: Expanding the Paradigm of Excitation/Inhibition Imbalance
por: Shao, Li-Rong, et al.
Publicado: (2019) -
The Glycolytic Metabolite, Fructose-1,6-bisphosphate, Blocks Epileptiform Bursts by Attenuating Voltage-Activated Calcium Currents in Hippocampal Slices
por: Shao, Li-Rong, et al.
Publicado: (2018) -
2‐deoxyglucose and β‐hydroxybutyrate fail to attenuate seizures in the betamethasone‐NMDA model of infantile spasms
por: Janicot, Remi, et al.
Publicado: (2021)